4.6 Letter

Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule?

Journal

THORAX
Volume 72, Issue 9, Pages 850-852

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2016-209841

Keywords

-

Funding

  1. European Community [FP7-223681]
  2. Oskar-Helene-Heim
  3. Gunther Labes

Ask authors/readers for more resources

WHO recently recommended the use of a shorter multidrug-resistant TB (MDR-TB) regimen under programmatic conditions. We assessed eligibility for this regimen in a cohort of 737 adult patients with MDR-TB from Latvia, Lithuania, Estonia and Bucharest city recruited in 2007 and 2009. Only 4.2% of the patients were eligible for this regimen. Ethambutol (64%), pyrazinamide resistance (58%) and previous exposure to second-line TB drugs were major reasons for non-eligibility. High-level resistance to isoniazid is expected due to widespread prevalence of katG mutations. In Eastern Europe, the use of the shorter regimen might be an exception rather than a rule.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Respiratory System

Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017-2019: an ECDC pilot study

Elisa Tagliani, Richard Anthony, Thomas A. Kohl, Albert de Neeling, Vlad Nikolayevskyy, Csaba Kodmon, Florian P. Maurer, Stefan Niemann, Dick van Soolingen, Marieke J. van der Werf, Daniela Maria Cirillo

Summary: This study evaluated the systematic use of whole genome sequencing (WGS) for Mycobacterium tuberculosis complex (MTBC) surveillance in European Union/European Economic Area (EU/EEA) countries and highlighted challenges and lessons learnt for future development of a WGS-based surveillance system. The results showed that a WGS-based surveillance system is not only feasible but can efficiently elucidate the dynamics of in-country and cross-border rifampicin-resistant (RR) and multidrug-resistant (MDR) tuberculosis transmission across EU/EEA countries. Lessons learnt from this study emphasize the need for strengthening national integrated systems and developing clear procedures for international collaboration in investigating cross-border clusters.

EUROPEAN RESPIRATORY JOURNAL (2021)

Letter Infectious Diseases

Reporting of interferon-gamma release assay results close to cut-off values

D. B. Folkvardsen, Y. Holicka, C. Kodmon, M. J. van der Were, T. Lillebaek, V. Nikolayevskyy

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)

Review Infectious Diseases

The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses

Delia Goletti, Linda Petrone, Davide Manissero, Antonio Bertoletti, Sonia Rao, Nduku Ndunda, Alessandro Sette, Vladyslav Nikolayevskyy

Summary: T-cell responses play a crucial role in COVID-19, providing early detection of disease progression and predictive value for severity and survival rates. Vaccination stimulates robust T-cell responses, contributing significantly to protective immunity, although understanding of long-term T-cell responses remains limited.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Letter Infectious Diseases

Current state of national TB laboratory networks in Europe: achievements and challenges

K. Klaos, Y. Holicka, R. Groenheit, C. Kodmon, M. J. van der Werf, V. Nikolayevskyy

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2022)

Review Infectious Diseases

The diagnostic performance of novel skin-based in-vivo tests for tuberculosis nfection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis

Maria Krutikov, Lena Faust, Vladyslav Nikolayevskyy, Yohhei Hamada, Rishi K. Gupta, Daniela Cirillo, Alberto Matteelli, Alexei Korobitsyn, Claudia M. Denkinger, Molebogeng X. Rangaka

Summary: This study systematically assessed the diagnostic performance of novel skin-based tests for tuberculosis infection compared to the TST and IGRA tests. The results showed that the novel skin-based tests performed similarly to IGRA or TST, but there were variations in study quality.

LANCET INFECTIOUS DISEASES (2022)

Article Immunology

Utility of the Whole Genome Sequencing based methodologies in routine European tuberculosis reference laboratory network setting

Yen Holicka, Elisa Tagliani, Daniela Maria Cirillo, Vlad Nikolayevskyy

Summary: This study aims to gather observational evidence of the impact of Whole Genome Sequencing (WGS) in the pathogen identification, antimicrobial resistance profiling and transmission tracking of tuberculosis. The study found that WGS significantly improved TB drug resistance testing and reduced false clustering. Further research is needed to assess the financial impact of WGS.

TUBERCULOSIS (2022)

Editorial Material Respiratory System

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

Sophia B. Georghiou, Timothy C. Rodwell, Alexei Korobitsyn, Said H. Abbadi, Kanchan Ajbani, Jan-Willem Alffenaar, David Alland, Nataly Alvarez, Sonke Andres, Elisa Ardizzoni, Alexandra Aubry, Rossella Baldan, Marie Ballif, Ivan Barilar, Erik C. Bottger, Soumitesh Chakravorty, Pauline M. Claxton, Daniela M. Cirillo, Inaki Comas, Chris Coulter, Claudia M. Denkinger, Brigitta Derendinger, Edward P. Desmond, Jurriaan E. M. de Steenwinkel, Keertan Dheda, Andreas H. Diacon, David L. Dolinger, Kelly E. Dooley, Matthias Egger, Maha R. Farhat, Lanfranco Fattorini, Iris Finci, Laure Fournier Le Ray, Victoria Furio, Ramona Groenheit, Tawanda Gumbo, Scott K. Heysell, Doris Hillemann, Harald Hoffmann, Po-Ren Hsueh, Yi Hu, Hairong Huang, Alamdar Hussain, Farzana Ismail, Kiyohiko Izumi, Tomasz Jagielski, John L. Johnson, Priti Kambli, Kone Kaniga, G. H. R. Eranga Karunaratne, Meenu Kaushal Sharma, Peter M. Keller, Ellis C. Kelly, Margarita Kholina, Mikashmi Kohli, Katharina Kranzer, Ian F. Laurenson, Jason Limberis, S-Y Grace Lin, Yongge Liu, Alexandre Lopez-Gavin, Anna Lyander, Diana Machado, Elena Martinez, Faisal Masood, Satoshi Mitarai, Nomonde R. Mvelase, Stefan Niemann, Vladyslav Nikolayevskyy, Florian P. Maurer, Matthias Merker, Paolo Miotto, Shaheed Omar, Ralf Otto-Knapp, Moises Palaci, Juan Jose Palacios Gutierrez, Sharon J. Peacock, Charles A. Peloquin, Jennifer Perera, Catherine Pierre-Audigier, Suporn Pholwat, James E. Posey, Therdsak Prammananan, Leen Rigouts, Jaime Robledo, Neesha Rockwood, Camilla Rodrigues, Max Salfinger, Marcos C. Schechter, Marva Seifert, Sarah Sengstake, Thomas Shinnick, Natalia Shubladze, Vitali Sintchenko, Frederick Sirgel, Sulochana Somasundaram, Timothy R. Sterling, Andrea Spitaleri, Elizabeth Streicher, Philip Supply, Erik Svensson, Elisa Tagliani, Sabira Tahseen, Akiko Takaki, Grant Theron, Gabriela Torrea, Armand Van Deun, Annelies Van Rie, Dick van Soolingen, Roger Vargas, Amour Venter, Nicolas Veziris, Cristina Villellas, Miguel Viveiros, Robin Warren, Shu'an Wen, Jim Werngren, Robert J. Wilkinson, Caie Yang, Tingting Zhang, Danila Zimenkov, Nazir Ismail, Thomas Schon, Claudio U. Koser, Soudeh Ehsani, Jakko van Ingen, F. Ferda Yilmaz

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Infectious Diseases

M. tuberculosis microvariation is common and is associated with transmission: Analysis of three years prospective universal sequencing in England

David Wyllie, Trien Do, Richard Myers, Vlad Nikolayevskyy, Derrick Crook, Tim Peto, Eliza Alexander, Esther Robinson, A. Sarah Walker, Colin Campbell, E. Grace Smith

Summary: Mixtures of transmissible strains occur in at least 5% of tuberculosis infections in England, and when present in pulmonary disease, such mixtures are associated with an increased risk of tuberculosis transmission.

JOURNAL OF INFECTION (2022)

Article Biochemical Research Methods

Accuracy of interferon gamma release assays for the COVID-19 immunity assessment

Francis Stieber, Nadia Allen, Kara Carpenter, Jenny Howard, Riccardo Alagna, Davide Manissero, Vladyslav Nikolayevskyy

Summary: Emerging evidence suggests the significant role of T-cells in COVID-19 immunity, and IGRA assays are considered attractive alternatives for accurate assessment. Adhering to good laboratory practice principles is important.

JOURNAL OF VIROLOGICAL METHODS (2022)

Review Respiratory System

Urine biomarkers of pulmonary tuberculosis

Elena Khimova, Ximena Gonzalo, Yulia Popova, Platon Eliseev, Maryandyshev Andrey, Vladyslav Nikolayevskyy, Agnieszka Broda, Francis Drobniewski

Summary: This review examines non-sputum diagnostic approaches for pulmonary tuberculosis based on urine samples, focusing on urine biomarkers. The analytical methods and designs vary among the studies, and only a few studies describe formal specificity and sensitivity analysis for diagnostic outcome prediction. Combining host and pathogen biomarkers may improve the sensitivity and specificity of tuberculosis diagnosis in the future.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2022)

Article Multidisciplinary Sciences

Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian Glade toward extensively drug resistant tuberculosis

Matthias Merker, Jean-Philippe Rasigade, Maxime Barbier, Helen Cox, Silke Feuerriegel, Thomas A. Kohl, Egor Shitikov, Kadri Klaos, Cyril Gaudin, Rudy Antoine, Roland Diel, Sonia Borrell, Sebastien Gagneux, Vladyslav Nikolayevskyy, Soenke Andres, Valeriu Crudu, Philip Supply, Stefan Niemann, Thierry Wirth

Summary: The research revealed that the W148 strain originated around 1963, and subsequently underwent two epidemic expansions in the late 20th century, developing resistance to multiple anti-TB drugs. The study also found that this strain carries a variety of drug resistance genes, posing a threat to the successful introduction of new anti-M/XDR-TB antibiotic regimens.

NATURE COMMUNICATIONS (2022)

Review Respiratory System

A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations

James Mahon, Sophie Beale, Hayden Holmes, Mick Arber, Vladyslav Nikolayevskyy, Riccardo Alagna, Davide Manissero, David Dowdy, Giovanni Battista Migliori, Giovanni Sotgiu, Raquel Duarte

Summary: This review examines the cost-effectiveness of testing and treatment for latent tuberculosis infection (LTBI) in high-risk groups using interferon gamma release assays (IGRAs) or a tuberculin skin test (TST). The results suggest that IGRAs are likely to be cost-effective in high-income countries for high-risk populations, although there is uncertainty in parameter values used in the studies. Further evidence is needed on the cost-effectiveness of different strategies in low to middle income countries and countries with high TB burden.

BMC PULMONARY MEDICINE (2022)

Letter Immunology

Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs

Hamzah Z. Farooq, Daniela M. Cirillo, Doris Hillemann, David Wyllie, Marieke J. van der Werf, Csaba Kodmon, Vlad Nikolayevskyy

Summary: In European laboratories, testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited.

EMERGING INFECTIOUS DISEASES (2021)

No Data Available